Alric R, Arce-Corrales L, Blayac J P, Puech R
Methods Find Exp Clin Pharmacol. 1984 Jul;6(7):353-61.
Analysis of variance both factorial and nested was used to validate a HPLC method intended for routine clinical assay of ethosuximide, phenobarbital, phenytoin and carbamazepine. Drugs were salted out, together with the solvent, from 0.5 ml acetonitrile-deproteinized plasma samples with 80-90% recovery. The acetonitrile extraction solution contained a known amount of all four drugs. This added amount of any drug was used when absent from plasma as an internal standard for those present and when present as a calibrator. Results showed that assay precision was acceptable (CV 6%) over and above the therapeutic range when additions did not exceed the lower therapeutic plasma level and if as many replications were made as there were drugs to assay. In return for some loss of sensitivity, reciprocal internal standardization provides increased assay reliability owing to the usual availability of more than one internal standard and to easier identification of interfering chromatographic peaks.
采用析因方差分析和嵌套方差分析来验证一种用于乙琥胺、苯巴比妥、苯妥英和卡马西平常规临床检测的高效液相色谱法。药物与溶剂一起从0.5 ml乙腈去蛋白血浆样品中盐析出来,回收率为80 - 90%。乙腈提取溶液中含有已知量的所有四种药物。当血浆中不存在某种药物时,添加的该药物量用作存在药物的内标;当存在时,则用作校准物。结果表明,当添加量不超过治疗血浆水平下限且检测的药物数量有多少就进行多少次重复检测时,在治疗范围之上检测精密度是可接受的(变异系数为6%)。作为灵敏度有所损失的回报,由于通常有不止一种内标可用且更容易识别干扰色谱峰,反向内标法提高了检测的可靠性。